Cigna Investments’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $716K | Buy |
21,124
+808
| +4% | +$26.9K | 0.09% | 182 |
|
|
2026
Q1 | $612K | Hold |
20,316
| – | – | 0.09% | 202 |
|
|
2025
Q4 | $634K | Sell |
20,316
-226
| -1% | -$5.57K | 0.09% | 189 |
|
|
2025
Q3 | $415K | Hold |
20,542
| – | – | 0.06% | 279 |
|
|
2025
Q2 | $344K | Hold |
20,542
| – | – | 0.06% | 312 |
|
|
2025
Q1 | $315K | Hold |
20,542
| – | – | 0.06% | 319 |
|
|
2024
Q4 | $452K | Hold |
20,542
| – | – | 0.08% | 242 |
|
|
2024
Q3 | $370K | Buy |
20,542
+82
| +0.4% | +$1.44K | 0.07% | 298 |
|
|
2024
Q2 | $332K | Buy |
20,460
+143
| +0.7% | +$2.2K | 0.06% | 310 |
|
|
2024
Q1 | $286K | Sell |
20,317
-474
| -2% | -$5.97K | 0.05% | 349 |
|
|
2023
Q4 | $217K | Hold |
20,791
| – | – | 0.04% | 402 |
|
|
2023
Q3 | $212K | Hold |
20,791
| – | – | 0.05% | 388 |
|
|
2023
Q2 | $157K | Hold |
20,791
| – | – | 0.03% | 446 |
|
|
2023
Q1 | $184K | Sell |
20,791
-1,405
| -6% | -$13.9K | 0.04% | 439 |
|
|
2022
Q4 | $203K | Buy |
22,196
+28
| +0.1% | +$244 | 0.04% | 433 |
|
|
2022
Q3 | $179K | Buy |
22,168
+593
| +3% | +$5.24K | 0.04% | 417 |
|
|
2022
Q2 | $163K | Buy |
21,575
+1,024
| +5% | +$8.92K | 0.03% | 444 |
|
|
2022
Q1 | $193K | Buy |
20,551
+4,144
| +25% | +$34.6K | 0.02% | 578 |
|
|
2021
Q4 | $131K | Hold |
16,407
| – | – | 0.01% | 642 |
|
|
2021
Q3 | $160K | Hold |
16,407
| – | – | 0.01% | 721 |
|
|
2021
Q2 | $162K | Hold |
16,407
| – | – | 0.01% | 736 |
|
|
2021
Q1 | $189K | Hold |
16,407
| – | – | 0.01% | 748 |
|
|
2020
Q4 | $159K | Buy |
16,407
+763
| +5% | +$7.31K | 0.01% | 711 |
|
|
2020
Q3 | $141K | Sell |
15,644
-930
| -6% | -$9.84K | 0.01% | 610 |
|
|
2020
Q2 | $204K | Sell |
16,574
-3,776
| -19% | -$42.7K | 0.02% | 681 |
|
|
2020
Q1 | $183K | Hold |
20,350
| – | – | 0.02% | 562 |
|
|
2019
Q4 | $212K | Buy |
20,350
+970
| +5% | +$8.66K | 0.02% | 608 |
|
|
2019
Q3 | $158K | Hold |
19,380
| – | – | 0.02% | 642 |
|
|
2019
Q2 | $154K | Buy |
19,380
+1,841
| +10% | +$22.2K | 0.02% | 645 |
|
|
2019
Q1 | $275K | Buy |
17,539
+197
| +1% | +$3.47K | 0.03% | 557 |
|
|
2018
Q4 | $267K | Buy |
17,342
+959
| +6% | +$19.7K | 0.02% | 570 |
|
|
2018
Q3 | $328K | Hold |
16,383
| – | – | 0.03% | 521 |
|
|
2018
Q2 | $398K | Buy |
16,383
+4,157
| +34% | +$84.8K | 0.03% | 494 |
|
|
2018
Q1 | $209K | Sell |
12,226
-296
| -2% | -$5.78K | 0.01% | 771 |
|
|
2017
Q4 | $238K | Sell |
12,522
-480
| -4% | -$7.22K | 0.02% | 779 |
|
|
2017
Q3 | $229K | Sell |
13,002
-461
| -3% | -$10.4K | 0.02% | 780 |
|
|
2017
Q2 | $447K | Sell |
13,463
-753
| -5% | -$23.3K | 0.03% | 486 |
|
|
2017
Q1 | $456K | Buy |
14,216
+3,941
| +38% | +$134K | 0.03% | 466 |
|
|
2016
Q4 | $372K | Buy |
+10,275
| New | +$410K | 0.04% | 486 |
|
Other funds holding TEVA
HIIFS
PF
CI
MMH
MIFH
LIM
Cigna Investments's TEVA Position: Q2 2026 in Review
Cigna Investments increased its Teva Pharmaceuticals (TEVA) stake by 4% in Q2 2026, buying an estimated $26.9K and bringing the position to 21,124 shares worth $716K. The position accounts for 0.09% of the portfolio, ranked #182.
Cigna Investments first reported a position in TEVA in Q4 2016 and has held it in 39 quarters since. 672 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.
- Cigna Investments held 21,124 shares of Teva Pharmaceuticals worth $716K as of Q2 2026.
- Cigna Investments bought 808 Teva Pharmaceuticals shares in Q2 2026, an estimated $26.9K.
- Teva Pharmaceuticals made up 0.09% of Cigna Investments's portfolio in Q2 2026, its #182 holding.
- Cigna Investments first reported a position in Teva Pharmaceuticals in Q4 2016 and has held it in 39 quarters since.
- 672 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.
Based on Cigna Investments's 13F filing for Q2 2026, filed 21 Jul 2026.